T1	Limited_variation	26 63	aromatase gene ( CYP19 ) polymorphism
T2	Pharmacodynamic_phenotype	72 114	circulating estradiol ( E2 ) levels , bone
T3	Phenotype	72 136	circulating estradiol ( E2 ) levels , bone mineral density ( BMD
T4	Phenotype	137 144	) , BMD
T5	Phenotype	145 170	change or fracture risk .
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	influences	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	influences	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T1
R10	isAssociatedWith	Arg1:T3	Arg2:T2
R11	isAssociatedWith	Arg1:T3	Arg2:T4
R12	isAssociatedWith	Arg1:T3	Arg2:T5
R13	isAssociatedWith	Arg1:T4	Arg2:T1
R14	isAssociatedWith	Arg1:T4	Arg2:T2
R15	isAssociatedWith	Arg1:T4	Arg2:T3
R16	isAssociatedWith	Arg1:T4	Arg2:T5
R17	isAssociatedWith	Arg1:T5	Arg2:T1
R18	isAssociatedWith	Arg1:T5	Arg2:T2
R19	isAssociatedWith	Arg1:T5	Arg2:T3
R20	isAssociatedWith	Arg1:T5	Arg2:T4
